+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liquid Biopsy"

From
From
From
Genetic Cancer Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Genetic Cancer Biomarkers - Global Strategic Business Report

  • Report
  • December 2025
  • 276 Pages
  • Global
From
From
Cancer Biopsies - Global Strategic Business Report - Product Thumbnail Image

Cancer Biopsies - Global Strategic Business Report

  • Report
  • December 2025
  • 380 Pages
  • Global
From
From
From
Biomarker Testing Services - Global Strategic Business Report - Product Thumbnail Image

Biomarker Testing Services - Global Strategic Business Report

  • Report
  • December 2025
  • 152 Pages
  • Global
From
Neurological Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Neurological Biomarkers - Global Strategic Business Report

  • Report
  • December 2025
  • 389 Pages
  • Global
From
From
From
In-Vitro Diagnostics Enzymes - Global Strategic Business Report - Product Thumbnail Image

In-Vitro Diagnostics Enzymes - Global Strategic Business Report

  • Report
  • December 2025
  • 478 Pages
  • Global
From
From
From
Fecal Occult Testing - Global Strategic Business Report - Product Thumbnail Image

Fecal Occult Testing - Global Strategic Business Report

  • Report
  • December 2025
  • 281 Pages
  • Global
From
From
From
Cancer Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Cancer Biomarkers - Global Strategic Business Report

  • Report
  • December 2025
  • 474 Pages
  • Global
From
Loading Indicator

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions. The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests. Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more